Idilman R, de Maria N, Uzunalimoglu O, van Thiel D H
Transplant Center, University of Kentucky, Lexington, USA.
Hepatogastroenterology. 1997 Mar-Apr;44(14):574-81.
The physiopathology, diagnosis and treatment of hepatic osteodystrophy are discussed in this review. Hepatic osteodystrophy (HO) is a generic definition for the metabolic bone disease that may occur in individuals with chronic liver disease. Two distinct bone metabolic processes, osteoporosis (OP) and osteomalacia (OM) are combined together in various proportions in HO syndromes. The relative importance of these two diseases in a given case is quite variable. HO is a common complication among individuals with long time lasting hepatic disease, particularly those with cholestasis. Since advanced HO is difficult to treat and adversely affects both the quality of life and the long-term prognosis of patients with chronic liver disease, special care is required in order to prevent the development of clinical bone disease in individuals with advanced hepatic disease.
本综述讨论了肝性骨营养不良的生理病理学、诊断和治疗。肝性骨营养不良(HO)是慢性肝病患者可能发生的代谢性骨病的统称。骨质疏松症(OP)和骨软化症(OM)这两种不同的骨代谢过程在HO综合征中以不同比例合并存在。在特定病例中,这两种疾病的相对重要性差异很大。HO是长期肝病患者,尤其是胆汁淤积患者常见的并发症。由于晚期HO难以治疗,且对慢性肝病患者的生活质量和长期预后均有不利影响,因此需要特别注意预防晚期肝病患者临床骨病的发生。